Perfil das demandas judiciais para o fornecimento de medicamentos no município de Rio Largo - AL

• Ano de defesa: 2016
• Autor(a) principal: Aires, Cláudia Cristina Nóbrega de Farias
• Tipo de documento: Dissertação
• Tipo de acesso: Acesso aberto
• Idioma: por
• Instituição de defesa: Universidade Federal de Alagoas; Brasil; Programa de Pós-Graduação em Ciências Farmacêuticas; UFAL
• Palavras-chave em Português: Direto à saúde; Medicamentos - Acesso; Judiciação; Saúde pública - Alagoas; Health right; Access to medicines; Judicialization; CNPQ::CIENCIAS DA SAUDE::FARMACIA
• Link de acesso: http://www.repositorio.ufal.br/handle/riufal/1575

The health is considered a social right, should the state promote and ensure universal and equal access to its programs and services. Law No. 8,080 / 90 establishes that the National Health System (SUS) to perform integrated care stocks, including pharmaceutical, explaining the importance of access to medicines for complete assistance. Despite the creation of various programs and strategies, not always implemented pharmaceutical assistance meets the needs of the patient, allowing his claim through the courts. The city of Rio Largo has been obliged to comply with court orders to supply drugs since 2007. The proposal is to evaluate the profile of lawsuits filed to supply drugs Rio Largo city, Alagoas state. This is a cross-sectional study with quantitative approach. The primary data source was the lawsuit requesting drug filed by citizens against the Rio Largo city during the period 2007 to 2014. The variables were: demographic profile member of the plaintiff, procedural characteristics, medical and health and political- administrative lawsuits. It was observed that the most prevalent age range of participants was 60-69 years (15.1%) and 79.6% of the authors of the actions had 1 to 2 minimum wages and family income. In 95.7% of the shares were public legal representation and 100% of them preliminary injunction was granted for the supply of medicines. The profile of the diseases most commonly found in this study directly influenced the anatomical group of the most prevalent drugs, represented by the gastrointestinal tract and metabolism group (26.1%). Only 34.9% of judicialized drugs were prescribed by generic name, 18.1% were available in one or more of the lists of existing essential drugs, however, 83.0% had an alternative therapy in the SUS and 23.8% were suitable for off-label use. In 2014, spending on judicialized drugs were equivalent to more than a third of the total invested in Basic Pharmaceutical Assistance. You see the need for more technical support to the judiciary so that action can be brought against the appropriate body or it can be suggested evaluating the possibility of replacing the defendant drug on the other, available in SUS, avoiding waste of public resources.